Yuji Iwanami

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Impact of an Empiric Isolation of the Superior Vena Cava in Addition to Circumferential Pulmonary Vein Isolation on the Outcome of Paroxysmal Atrial Fibrillation Ablation

Koichiro Ejima, Ken Kato, Yuji Iwanami et al. · The American Journal of Cardiology · 2015 · 55 citations

Pulmonary Embolism, Empiric Isolation, Cardiac Anaesthesia +7

Appendicular Skeletal Muscle Mass Correlates with Patient-Reported Outcomes and Physical Performance in Patients with Idiopathic Pulmonary Fibrosis

Kento Ebihara, Yuji Iwanami, Keiko Yamasaki et al. · The Tohoku Journal of Experimental Medicine · 2021 · 24 citations · Full text

Comparison of the Efficacy of Empiric Thoracic Vein Isolation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation in Patients Without Structural Heart Disease

Koichiro Ejima, Ryuta Henmi, Yuji Iwanami et al. · Journal of Cardiovascular Electrophysiology · 2017 · 21 citations

Using 6-Min Walk Distance Expressed as a Percentage of Reference to Evaluate the Effect of Pulmonary Rehabilitation in Elderly Patients With Interstitial Lung Disease

Ai Igarashi, Yuji Iwanami, Keishi Sugino et al. · Journal of Cardiopulmonary Rehabilitation and Prevention · 2018 · 17 citations